Clinical Trials on Cytomegalovirus (CMV) Infection

Total 60934 results

National Institute of Allergy and Infectious Diseases...

Completed

Valganciclovir in Congenital CMV Infants

Cytomegalovirus Infections

United States
Fondazione Onlus Camillo De Lellis
Regione Abruzzo, Italy; Azienda Sanitaria Locale di Pescara

Unknown

Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection

Cytomegalovirus Congenital Infection

Italy
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus

Kidney Transplant Infection | Cytomegalovirus Disease

United States
Astellas Pharma Global Development, Inc.
Vical

Completed

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Healthy Subjects | Cytomegalovirus Infection | Dialysis

United States
Salvador Gil-Vernet
Roche Pharma AG

Completed

Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Cytomegalovirus Infection

Spain
Shenzhen Geno-Immune Medical Institute

Unknown

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Tuberculosis | CMV Infection | EBV Infection | Adenovirus Infection | Fungus Infection | Pathogen Infection | BKV Infection

China
St. Anna Kinderkrebsforschung

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (VISIT)

Cytomegalovirus Infection | Adenovirus Infection

Austria
Chiron Corporation

Completed

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Cytomegalovirus Infection

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

Cytomegalovirus Infection | Healthy, no Evidence of Disease

United States
Maimónides Biomedical Research Institute of Córdoba
MERCK SHARP & DOHME DE ESPAÑA S.A.

Not yet recruiting

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. (LETERCOR)

Infections, Cytomegalovirus

Spain
GlaxoSmithKline

Completed

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

Cytomegalovirus Infections | Infections, Cytomegalovirus

Belgium
Takeda

Not yet recruiting

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Kidney Failure | Cytomegalovirus (CMV) | Kidney Disease
Beijing Chao Yang Hospital

Unknown

The Link Between Human Cytomegalovirus (HCMV) and Hypertension

Hypertension | HCMV Infection

China
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
Hospital do Rim e Hipertensão

Completed

Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

Cytomegalovirus Infection | Transplant; Complication, Rejection | Renal Transplant Failure

Brazil
Southern Illinois University
University of Alabama at Birmingham

Completed

Screening for Congenital Cytomegalovirus Infection in Newborns (CMV)

Cytomegalovirus Infections
SL VAXiGEN
SL BIGEN

Unknown

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

BK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus Reactivation

Korea, Republic of
Professor Lorraine Harper
Wellcome Trust

Unknown

CMV Modulation of the Immune System in ANCA-associated Vasculitis (CANVAS)

ANCA Associated Vasculitis | CMV Infection

United Kingdom
University of Pennsylvania

Completed

Cytomegalovirus (CMV) Infection in Pregnancy

Pregnancy Complications | Cytomegalovirus Infection

United States
Hanoi Obstetrics and Gynecology Hospital
Hôpital Necker-Enfants Malades

Recruiting

Congenital CYtoMEgalovirus Infection in VIEtnam (CYMEVIE) (CYMEVIE)

Neonatal Disease | Prenatal Infection | Congenital Infection

Vietnam
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche; Astra USA

Completed

A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins University

Completed

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component

HIV Infections | Cytomegalovirus Retinitis

United States
Agouron Pharmaceuticals

Completed

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Astra USA

Completed

An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients

HIV Infections | Cytomegalovirus Retinitis

United States
Dr mohammedRmadan hamad
Assiut University

Unknown

Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis

Cmv Colitis
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir

HIV Infections | Cytomegalovirus Retinitis
Astra USA

Completed

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
Hoffmann-La Roche

Completed

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
GlaxoSmithKline

Completed

Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

Infections, Cytomegalovirus

Belgium
GlaxoSmithKline

Completed

Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects

Infections, Cytomegalovirus

Belgium
Shahid Beheshti University of Medical Sciences

Completed

Comparison of Safety and Efficacy of de Novo Everolimus

Cytomegalovirus Infections

Iran, Islamic Republic of
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
VBI Vaccines Inc.
Clinical Trial Data Services, LLC

Completed

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Cytomegalovirus Infections

Canada
Fundacio Catalana de Pneumologia
Roche Farma, S.A

Completed

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive (REIVI)

Cytomegalovirus Infections

Spain
University of Bologna

Unknown

Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy (PROTECT)

Heart Transplantation | Cytomegalovirus Infection | Cardiac Allograft Vasculopathy

Italy
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Completed

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Terminated

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial (CONCERT)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
Schering-Plough

Completed

Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Nobelpharma

Completed

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Cytomegalovirus Disease

United States, Japan
St George's, University of London
University College, London; University of Cambridge; Kingston University; CMV Action

Completed

Reducing Acquisition of CMV Through Antenatal Education (RACEFIT)

Cytomegalovirus Congenital

United Kingdom
Genentech, Inc.

Completed

A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients

Cytomegalovirus Infections

United States, Belgium, Spain, Sweden, United Kingdom, France, Germany, Norway
Chimerix

Terminated

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease (SUSTAIN)

Cytomegalovirus Disease

United States
Emory University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

TT-CMV Observational Birth Cohort Study (TT-CMV)

Cytomegalovirus Disease

United States
Marcus Saemann

Unknown

Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients (Certi-CMV)

Cytomegalovirus Disease

Austria
Tufts Medical Center
Merck Sharp & Dohme LLC

Active, not recruiting

Letermovir Use in Heart Transplant Recipients

Neutropenia | Cytomegalovirus Infections | Cytomegalovirus Disease | Heart Transplant Infection | Antiviral Toxicity

United States

Clinical Trials on Cytomegalovirus (CMV) Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations